↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "WFRF:(Rossi L.) ;hsvcat:3"

Search: WFRF:(Rossi L.) > Medical and Health Sciences

Result 1-10 of 106

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Glasbey, JC, et al. (author) Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 2021 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. - : American Society of Clinical Oncology. - 1527-7755 .- 0732-183X. ; 39:1, s. 66- Journal article (peer-reviewed)
2.	Bhangu, A, et al. (author) Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study 2018 In: The Lancet. Infectious diseases. - : Elsevier. - 1474-4457 .- 1473-3099. ; 18:5, s. 516-525 Journal article (peer-reviewed)
3.	Ray, KK, et al. (author) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 2019 In: The lancet. Diabetes & endocrinology. - 2213-8595 .- 2213-8587. ; 7:8, s. 618-628 Journal article (peer-reviewed)
4.	Jukema, JW, et al. (author) Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1167-1176 Journal article (peer-reviewed)
5.	Roe, MT, et al. (author) Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes 2019 In: Circulation. - : Ovid Technologies (Wolters Kluwer Health). - 1524-4539 .- 0009-7322. ; 140:19, s. 1578-1589 Journal article (peer-reviewed)
6.	Szarek, M, et al. (author) Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial 2019 In: Circulation. Cardiovascular quality and outcomes. - : Ovid Technologies (Wolters Kluwer Health). - 1941-7705 .- 1941-7713. ; 12:11, s. e005858- Journal article (peer-reviewed)
7.	Szarek, M, et al. (author) Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 73:4, s. 387-396 Journal article (peer-reviewed)
8.	Ridker, PM, et al. (author) Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients 2017 In: The New England journal of medicine. - 1533-4406 .- 0028-4793. ; 376:16, s. 1527-1539 Journal article (peer-reviewed)
9.	de Rojas, I., et al. (author) Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 2021 In: Nature Communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 12:1 Journal article (peer-reviewed)abstract Genetic discoveries of Alzheimer’s disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n = 409,435 and validation size n = 58,190). Here, we add six variants associated with Alzheimer’s disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer’s disease patients in APOE ɛ4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer’s disease. © 2021, The Author(s).
10.	Bittner, VA, et al. (author) Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome 2020 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 75:2, s. 133-144 Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 106

Refine your search

Type of publication: journal article (100); research review (3); conference paper (2); reports (1)

Type of content: peer-reviewed (97); other academic/artistic (9)

Author/Editor: Müller, C. (11); ROSSI, P (11); Rossi, G (11); Ahmed, H. (10); Anderson, J (10); Zhang, XL (10); show more...; Sandhu, M. (10); Whitaker, J (10); Berti, S (10); Li, Y. (9); Schmidt, E. (9); Kumar, A. (9); Davies, R (9); Khan, M (9); Katz, A. (9); Huang, L. (9); Rossi, D (9); Janik, M (9); Jukema, JW (9); Lee, K (9); Kim, C. (9); Fazekas, F. (9); Ferrari, E. (9); Filardi, PP (9); Mach, F (9); Stewart, R (9); Witt, N (9); Shechter, M (9); Malik, A (9); Probst, V. (9); Laufs, U (9); Baranova, E (9); de Silva, HA (9); Stellbrink, C (9); Dion, D (9); Kim, SH (9); Mehta, S (9); Rasmanis, G (9); Aylward, PE (9); Moriarty, PM (9); Karpov, Y (9); Murin, J (9); Tunon, J (9); Chiang, CE (9); Sritara, P (9); Caccavo, A (9); Mackinnon, IJ (9); Codutti, OR (9); Jure, HO (9); Zaidman, CJ (9); show less...

University: Karolinska Institutet (48); Lund University (40); Uppsala University (29); University of Gothenburg (28); Örebro University (6); Umeå University (5); show more...; Stockholm University (5); Royal Institute of Technology (4); Linköping University (4); Chalmers University of Technology (2); Jönköping University (1); Karlstad University (1); Högskolan Dalarna (1); show less...

Language: English (105); Undefined language (1)

Research subject (UKÄ/SCB): Medical and Health Sciences (106)Undo refine; Natural sciences (6); Engineering and Technology (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view